Archford Capital Strategies »

ResMed shares owned by Archford Capital Strategies

Quarter-by-quarter ownership of ResMed (RMD) shares owned by Archford Capital Strategies from 13F filings

Historical chart of Archford Capital Strategies investment in ResMed

Tip: Access up to 7 years of quarterly data

All positions including ResMed held by Archford Capital Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ResMed by Archford Capital Strategies

Quarter filed Position value Share count Share price at filing
2024-09-30 $210k 872 240.71
2022-03-31 $213k 867 245.67
2021-09-30 $228k 867 262.98
2021-06-30 $214k 867 246.83
2014-09-30 $2.0k 38 52.63
2014-06-30 $2.9k 58 50.62

More positions owned by Archford Capital Strategies

Vanguard Growth Etf Growth Etf (VUG)
Vanguard Total Bond Market Etf Total Bnd Mrkt (BND)
Ishares Core Msci Eafe Etf Core Msci Eafe (IEFA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Vanguard Value Etf Value Etf (VTV)
Vanguard Dividend Appreciation Etf Div App Etf (VIG)
Schwab U.s. Large-cap Growth Etf Us Lcap Gr Etf (SCHG)
Vaneck Morningstar Wide Moat Etf Mrngstr Wde Moat (MOAT)
Visa Inc Com Cl A Com Cl A (V)
Jpmorgan Betabuilders U.s. Equity Etf Betabuildrs Us (BBUS)
Invesco Russell 1000 Dynamic Multifactor Etf Rusl 1000 Dynm (OMFL)
Vanguard Intermediate-term Treasury Etf Inter Term Treas (VGIT)
Schwab Fundamental International Equity Etf Fundamental Intl (FNDF)
Amazon (AMZN)

View all positions for Archford Capital Strategies

Top funds holding ResMed

Vanguard Group
BlackRock
State Street Corporation
Bank of New York Mellon
Geode Capital Management
Invesco
Northern Trust
Legal & General Group
Select Equity
Charles Schwab Investment Management
Goldman Sachs Group
Ubs Global Asset Management Americas
Greenvale Capital
Dimensional Fund Advisors
Jpmorgan Chase & Co

View all funds holding ResMed